)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Cardiff Oncology
Cardiff Oncology (CRDF) investor relations material
Cardiff Oncology Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary14 Aug, 2026
Executive summary
Special Meeting scheduled for October 2026 to vote on two key proposals regarding capital structure and meeting adjournment.
Board recommends approval of both proposals to increase authorized shares and allow adjournment if needed.
Proxy materials are available online, and shareholders are encouraged to vote by internet or mail for convenience.
Voting matters and shareholder proposals
Proposal 1 seeks to amend the Certificate of Incorporation to increase authorized capital stock from 170M to 320M and common stock from 150M to 300M.
Proposal 2 allows adjournment of the meeting to solicit more proxies if Proposal 1 lacks sufficient votes.
Both proposals require a majority of shares present in person or by proxy to pass.
Board recommends voting "FOR" both proposals.
No appraisal rights are available for these matters.
Board of directors and corporate governance
Board approved the proposed amendment on August 12, 2026.
Board and executive officers have an interest in both proposals.
Board retains discretion to abandon the amendment if deemed not in the best interests of the company.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Cardiff Oncology
- Phase 2 success for onvansertib in mCRC; cash runway into Q3 2027, but litigation risk remains.CRDF
Q2 2026 - Onvansertib shows strong efficacy and safety in first-line RAS-mutated MCRC, with major updates due in Q1 2026.CRDFNoble Capital Markets Emerging Growth Virtual Investor Conference
- Advancing a well-tolerated PLK1 inhibitor to global phase III for RAS-mutated colorectal cancer.CRDFJefferies Global Healthcare Conference 2026
- 30 mg onvansertib plus FOLFIRI-BEV delivers 72.2% ORR and durable benefit in RAS-mutated mCRC.CRDFStatus update
- Positive Phase 2 data, FDA alignment, and narrowed net loss offset by ongoing going concern risk.CRDFQ1 2026
- Annual meeting covers director elections, auditor ratification, equity plan amendment, and say-on-pay.CRDFProxy filing
- Shareholders will vote on directors, auditor ratification, equity plan changes, and executive pay.CRDFProxy filing
- Onvansertib plus FOLFIRI+BEV achieved a 72% response rate and strong PFS in RAS mutated CRC.CRDFKOL event
- Onvansertib shows 72% ORR and robust PFS in RAS-mutated mCRC, advancing to phase III trials.CRDFOppenheimer 36th Annual Healthcare Life Sciences Conference
Next Cardiff Oncology earnings date
Q3 20266 Nov, 2026
Cardiff Oncology
Next Cardiff Oncology earnings date
Q3 20266 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage